Skip to content
Screener

BioLife Solutions BLFS Q2 2026 earnings

Reported August 6, 2026 · After market close

Revenue$28.5MBeat by $669.6K
EPS$0.91Beat by $0.88
Revenue estimate$27.8M
EPS estimate$0.03
“We delivered another strong quarter, with solid execution across the business led by our market-leading biopreservation media franchise, This continued performance underscores the important role our technologies play in enabling the advancement of cell and gene therapies. We look forward to building on this foundation through our announced combination with Repligen, which is expected to close in the fourth quarter of 2026.”
Management

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$29.2M
EPS estimate$0.01

Financials

Q2 2026

Income statement

See full
Revenue$28.5M+21.5%
Gross profit$18.3M+20.0%
Operating income$1.7M+111%
Net income$45.1M+385%
EPS (diluted)$0.91+376%

Balance sheet

See full
Cash & equivalents$24.0M-24.8%
Total debt$15.7M-33.9%
Total equity$420.0M+21.0%
Total assets$447.5M+15.6%

Cash flow

See full
Operating cash flow$6.3M-13.8%
CapEx$1.0M-40.2%
Free cash flow$5.3M-5.7%

Valuation & ratios

Valuation

as of 09/18/26
See full
Market cap$1.8B+43.2%
Enterprise value$1.79B+43.5%
P/E58×—
P/S17.5×+2.2×

Profitability

See full
Operating margin1.6%—

Returns & leverage

See full
Debt / equity0×0.0×
Current ratio9.7×+5.3×

FAQ

When did BioLife Solutions report Q2 2026 earnings?
BioLife Solutions (BLFS) reported Q2 2026 earnings on August 6, 2026 after market close.
What were BioLife Solutions's Q2 2026 revenue and EPS?
BioLife Solutions reported revenue of $28.5M and eps of $0.91 for Q2 2026.
Did BioLife Solutions beat estimates in Q2 2026?
Revenue beat the consensus estimate of $27.8M by $669.6K. EPS beat the consensus estimate of $0.03 by $0.88.
How did BioLife Solutions's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 12.0% from $25.4M a year earlier.
Where can I find BioLife Solutions's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-051964) and the 10-Q periodic report (0001628280-26-054355) directly on SEC EDGAR. The filing index links above go to sec.gov.